Mackenzie Financial’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,169,608
Closed -$51.4M 1113
2020
Q3
$51.4M Sell
1,169,608
-210,513
-15% -$10.4M 0.13% 171
2020
Q2
$61M Sell
1,380,121
-13,900
-1% -$519K 0.16% 150
2020
Q1
$50M Hold
1,394,021
0.16% 151
2019
Q4
$98.8M Buy
1,394,021
+204,473
+17% +$14.8M 0.24% 113
2019
Q3
$89M Sell
1,189,548
-311,518
-21% -$26.4M 0.23% 110
2019
Q2
$121M Buy
1,501,066
+226,334
+18% +$15.9M 0.31% 85
2019
Q1
$85.3M Buy
1,274,732
+566,338
+80% +$42.9M 0.21% 114
2018
Q4
$52.7M Buy
708,394
+506,094
+250% +$41.8M 0.14% 150
2018
Q3
$18.6M Buy
+202,300
New +$19.3M 0.05% 244
2017
Q2
Sell
-2,682
Closed -$215K 686
2017
Q1
$215K Sell
2,682
-6,750
-72% -$536K ﹤0.01% 600
2016
Q4
$743K Sell
9,432
-4,570
-33% -$355K ﹤0.01% 474
2016
Q3
$1.09M Buy
+14,002
New +$1.02M 0.01% 402

Other funds holding CMD

Mackenzie Financial's CMD Position: Q4 2020 in Review

Mackenzie Financial sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 1,169,608 shares — an estimated $51.4M sold.

Mackenzie Financial first reported a position in CMD in Q3 2016 and held it in 12 quarters. The position peaked at $121M in Q2 2019. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Mackenzie Financial reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • Mackenzie Financial sold 1,169,608 Cantel Medical Corporation shares in Q4 2020, an estimated $51.4M.
  • Mackenzie Financial first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 12 quarters.
  • Mackenzie Financial's Cantel Medical Corporation position peaked at $121M in Q2 2019.
  • 229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Mackenzie Financial's 13F filing for Q4 2020, filed 10 Feb 2021.